Healius Ltd (HLS) - Total Liabilities
Based on the latest financial reports, Healius Ltd (HLS) has total liabilities worth AU$1.22 Billion AUD (≈ $860.68 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HLS shareholders equity momentum to track the company's year-over-year net asset growth rate.
Healius Ltd - Total Liabilities Trend (1998–2025)
This chart illustrates how Healius Ltd's total liabilities have evolved over time, based on quarterly financial data. See Healius Ltd (HLS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Healius Ltd Competitors by Total Liabilities
The table below lists competitors of Healius Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Globa Terra Acquisition Corporation Class A Ordinary Shares
NASDAQ:GTERA
|
USA | $1.21 Million |
|
Pondy Oxides & Chemicals Limited
NSE:POCL
|
India | Rs815.66 Million |
|
Lithium Royalty Corp
TO:LIRC
|
Canada | CA$2.82 Million |
|
GuocoLand (Malaysia) Bhd
KLSE:1503
|
Malaysia | RM874.57 Million |
|
Studsvik AB
ST:SVIK
|
Sweden | Skr618.90 Million |
|
Repro Med Systems Inc
NASDAQ:KRMD
|
USA | $11.67 Million |
|
Indeks Bilgisayar Sistemleri Muhendislik Sanayi ve Ticaret AS
IS:INDES
|
Turkey | TL25.32 Billion |
|
Nkarta Inc
NASDAQ:NKTX
|
USA | $86.21 Million |
Liability Composition Analysis (1998–2025)
This chart breaks down Healius Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see HLS market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Healius Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Healius Ltd (1998–2025)
The table below shows the annual total liabilities of Healius Ltd from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$1.19 Billion ≈ $841.36 Million |
-38.77% |
| 2024-06-30 | AU$1.94 Billion ≈ $1.37 Billion |
-9.54% |
| 2023-06-30 | AU$2.15 Billion ≈ $1.52 Billion |
-3.08% |
| 2022-06-30 | AU$2.22 Billion ≈ $1.57 Billion |
+15.08% |
| 2021-06-30 | AU$1.92 Billion ≈ $1.36 Billion |
-27.55% |
| 2020-06-30 | AU$2.66 Billion ≈ $1.88 Billion |
+104.13% |
| 2019-06-30 | AU$1.30 Billion ≈ $920.96 Million |
-0.44% |
| 2018-06-30 | AU$1.31 Billion ≈ $925.07 Million |
+5.01% |
| 2017-06-30 | AU$1.25 Billion ≈ $880.92 Million |
+4.02% |
| 2016-06-30 | AU$1.20 Billion ≈ $846.88 Million |
-20.35% |
| 2015-06-30 | AU$1.50 Billion ≈ $1.06 Billion |
+9.59% |
| 2014-06-30 | AU$1.37 Billion ≈ $970.19 Million |
+5.00% |
| 2013-06-30 | AU$1.31 Billion ≈ $924.02 Million |
+1.33% |
| 2012-06-30 | AU$1.29 Billion ≈ $911.93 Million |
-2.45% |
| 2011-06-30 | AU$1.32 Billion ≈ $934.88 Million |
+7.77% |
| 2010-06-30 | AU$1.23 Billion ≈ $867.48 Million |
-26.22% |
| 2009-06-30 | AU$1.66 Billion ≈ $1.18 Billion |
-45.28% |
| 2008-06-30 | AU$3.04 Billion ≈ $2.15 Billion |
+1440.96% |
| 2007-06-30 | AU$197.10 Million ≈ $139.46 Million |
+29.66% |
| 2006-06-30 | AU$152.01 Million ≈ $107.56 Million |
+18.86% |
| 2005-06-30 | AU$127.89 Million ≈ $90.49 Million |
+23.17% |
| 2004-06-30 | AU$103.83 Million ≈ $73.47 Million |
-2.08% |
| 2003-06-30 | AU$106.04 Million ≈ $75.03 Million |
-4.31% |
| 2002-06-30 | AU$110.81 Million ≈ $78.41 Million |
+1.25% |
| 2001-06-30 | AU$109.44 Million ≈ $77.44 Million |
+110.49% |
| 2000-06-30 | AU$51.99 Million ≈ $36.79 Million |
+33.66% |
| 1999-06-30 | AU$38.90 Million ≈ $27.52 Million |
+163.58% |
| 1998-06-30 | AU$14.76 Million ≈ $10.44 Million |
-- |
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more